P B Zanzonico

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Radiat Res 177:349-64. 2012
  2. ncbi Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus
    Dana Haddad
    Department of Biochemistry, University of Wuerzburg, Wuerzburg D 97074, Germany
    J Transl Med 9:36. 2011
  3. ncbi PET-based biological imaging for radiation therapy treatment planning
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Rev Eukaryot Gene Expr 16:61-101. 2006
  4. ncbi [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Eur J Nucl Med Mol Imaging 33:988-97. 2006
  5. ncbi Routine quality control of clinical nuclear medicine instrumentation: a brief review
    Pat Zanzonico
    Departments of Medical Physics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 49:1114-31. 2008
  6. ncbi Introduction to clinical and laboratory (small-animal) image registration and fusion
    Pat B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Conf Proc IEEE Eng Med Biol Soc 1:1580-3. 2006
  7. ncbi Broad-spectrum multi-modality image registration: from PET, CT, and MRI to autoradiography, microscopy, and beyond
    P B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Conf Proc IEEE Eng Med Biol Soc 1:1584-8. 2006
  8. ncbi Patient-specific radiation dosimetry for radionuclide therapy of liver tumors with intrahepatic artery rhenium-188 lipiodol
    Pat B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Nucl Med 38:S30-9. 2008
  9. ncbi Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities
    Pat Zanzonico
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Health Phys 95:554-70. 2008
  10. ncbi Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nucl Med Biol 33:65-70. 2006

Detail Information

Publications54

  1. ncbi Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Radiat Res 177:349-64. 2012
    ..These include gamma cameras, single-photon emission computed tomography (SPECT) scanners, and positron emission tomography (PET) scanners. The technical basis of autoradiography is reviewed as well...
  2. ncbi Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus
    Dana Haddad
    Department of Biochemistry, University of Wuerzburg, Wuerzburg D 97074, Germany
    J Transl Med 9:36. 2011
    ..This study aimed to determine if insertion of the human sodium iodide symporter (hNIS) cDNA as a marker for non-invasive imaging of virotherapy alters the replication and oncolytic capability of a novel vaccinia virus, GLV-1h153...
  3. ncbi PET-based biological imaging for radiation therapy treatment planning
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Rev Eukaryot Gene Expr 16:61-101. 2006
    ..It remains unclear, however, whether PET is currently capable of delineating the true extent of viable tumor with sufficient accuracy and precision to reliably guide therapy on a routine basis...
  4. ncbi [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Eur J Nucl Med Mol Imaging 33:988-97. 2006
    ....
  5. ncbi Routine quality control of clinical nuclear medicine instrumentation: a brief review
    Pat Zanzonico
    Departments of Medical Physics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 49:1114-31. 2008
    ..It should be particularly useful for residents, fellows, and other trainees in nuclear medicine, nuclear cardiology, and radiology. The procedures described and their respective frequencies are presented only as general guidelines...
  6. ncbi Introduction to clinical and laboratory (small-animal) image registration and fusion
    Pat B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Conf Proc IEEE Eng Med Biol Soc 1:1580-3. 2006
    ..g. PET-CT, devices which provide registered and fused three-dimensional image sets. This paper briefly reviews the basics of image registration and fusion and available clinical and small-animal multi-modality instrumentation...
  7. ncbi Broad-spectrum multi-modality image registration: from PET, CT, and MRI to autoradiography, microscopy, and beyond
    P B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Conf Proc IEEE Eng Med Biol Soc 1:1584-8. 2006
    ....
  8. ncbi Patient-specific radiation dosimetry for radionuclide therapy of liver tumors with intrahepatic artery rhenium-188 lipiodol
    Pat B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Nucl Med 38:S30-9. 2008
    ..Although not required for treatment planning, tumor absorbed dose may also be estimated. This algorithm has been automated using an Excel (Microsoft, Redmond, WA) spreadsheet...
  9. ncbi Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities
    Pat Zanzonico
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Health Phys 95:554-70. 2008
    ..The radiation burden accrued by the patients undergoing PET-CT or SPECT-CT exams will be considered as well...
  10. ncbi Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors
    Pat Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nucl Med Biol 33:65-70. 2006
    ....
  11. ncbi Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout
    P B Zanzonico
    Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Health Phys 78:660-7. 2000
    ....
  12. ncbi A generalized algorithm for determining the time of release and the duration of post-release radiation precautions following radionuclide therapy
    P B Zanzonico
    Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Health Phys 78:648-59. 2000
    ..Even so, dose-based release criteria should prove more cost-effective overall than hospitalization of patients commonly imposed by activity-based and dose rate-based release criteria...
  13. ncbi Model-based versus patient-specific dosimetry: blurring the lines
    Pat B Zanzonico
    Memorial Sloan-Kettering Cancer Center New York, New York 10021, USA
    J Nucl Med 43:1665-6. 2002
  14. ncbi Enhancement of radioiodine treatment of small-pool hyperthyroidism with antithyroid drugs: kinetics and dosimetry
    Pat B Zanzonico
    Division of Nuclear Medicine, New York Presbyterian Hospital, New York, USA
    J Nucl Med 45:2102-8. 2004
    ....
  15. ncbi Age-dependent thyroid absorbed doses for radiobiologically significant radioisotopes of iodine
    P B Zanzonico
    Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Health Phys 78:60-7. 2000
    ..Although the thyroid absorbed dose for inhalation is substantially (30 to 70%) less than that for injection for all radioiodines and at all ages, it is markedly (25%) less for ingestion only for short-lived 132I...
  16. ncbi Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose
    Gregor J Förster
    Nuclear Medicine Research Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Nucl Med 47:140-9. 2006
    ..The objective of the current study, therefore, was to evaluate the reduction of kidney uptake of radiolabeled DOTA-biotin achieved by each of 4 different methods...
  17. ncbi Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene
    Peter Brader
    Departments of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 15:3791-801. 2009
    ....
  18. ncbi A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia
    Bixiu Wen
    Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY, New York 10021, USA
    Eur J Nucl Med Mol Imaging 31:1530-8. 2004
    ....
  19. ncbi Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
    Guenther Koehne
    Allogeneic Bone Marrow Transplantation Service, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Nat Biotechnol 21:405-13. 2003
    ..This technique for imaging the migration of ex vivo-transduced antigen-specific T cells in vivo is informative, nontoxic, and potentially applicable to humans...
  20. ncbi Visualization of experimental lung and bone metastases in live nude mice by X-ray micro-computed tomography
    Xiao Feng Li
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Technol Cancer Res Treat 5:147-55. 2006
    ..Micro-CT may be used as an accurate, noninvasive tool to detect and monitor experimental bone and lung metastases in intact live nude mice...
  21. ncbi Bisphosphonate delivery to tubular bone allografts
    Gene R DiResta
    Department of Surgery Orthopaedic Surgical Service, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Ave, Suite A342, New York, NY 10065 6004, USA
    Clin Orthop Relat Res 466:1871-9. 2008
    ..Flow resistance was reduced with octylphenoxy polyethoxy ethanol but unaffected with beractant. Pumped allografts displayed a more homogeneous indicator distribution in less time than soaking while surfactants enhanced fluid movement...
  22. ncbi Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
    Kim Kramer
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 429, New York, NY 10065, USA
    J Neurooncol 97:409-18. 2010
    ..The cRIT-salvage regimen for CNS metastases was well tolerated by young patients, despite their prior history of intensive cytotoxic therapies. It has the potential to increase survival with better than expected quality of life...
  23. ncbi Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent mic
    Joseph A O'Donoghue
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 61:1493-502. 2005
    ..To compare two potential positron emission tomography (PET) tracers of tumor hypoxia in an animal model...
  24. ncbi Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor
    Jaspreet Singh Jaggi
    Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Clin Invest 117:2422-30. 2007
    ..The ability to reduce the serum persistence of conjugated IgG antibodies after their infusion can enhance their therapeutic index, resulting in improved therapeutic and diagnostic efficacy...
  25. ncbi A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements
    Jenghwa Chang
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Med Phys 36:5301-9. 2009
    ....
  26. ncbi Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Health Phys 92:33-9. 2007
    ....
  27. ncbi Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system
    Oula Penate Medina
    Molecular Pharmacology and Chemistry Department, Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue 10021 New York, New York, United States
    J Control Release 149:292-8. 2011
    ..SKI 243 and liposomal SKI 243 are both taken up by tumor xenografts but liposomal SKI 243 remained in the blood longer and consequently exhibited a 3- to 6-fold increase in uptake in the tumor among several other organs...
  28. ncbi Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2
    Nai Kong V Cheung
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 45:867-77. 2004
    ..Neuroblastoma is uniquely suited for such investigations because of its abundance of surface ganglioside GD2...
  29. ncbi Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning
    Pat Zanzonico
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Eur J Nucl Med Mol Imaging 31:117-28. 2004
    ....
  30. ncbi Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging
    Peter Brader
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Cancer Res 14:2295-302. 2008
    ..Imaging bacteria specifically targeting and replicating within tumors using radiotracer techniques and optical imaging can provide confirmation of successful colonization of malignant tissue...
  31. ncbi Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort
    Christopher C Riedl
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur J Nucl Med Mol Imaging 35:39-46. 2008
    ....
  32. ncbi In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene
    Mikhail M Doubrovin
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 67:11959-69. 2007
    ..The hNET-based system described may thus have significant potential as a nonimmunogenic reporter for extended repeated quantitative in vivo imaging of transduced cells in man...
  33. ncbi Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET
    Bradley J Beattie
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 51:183-92. 2010
    ....
  34. ncbi Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
    Omer Ugur
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Nucl Med Biol 29:147-57. 2002
    ..66Ga-DOTATOC may also be used in higher doses for ablation of these tumors. However, kidney is the critical organ for toxicity (tumor/kidney ratio = 1.64), and high kidney uptake must be eliminated before devising a therapy protocol...
  35. ncbi Optical bioluminescence imaging of human ES cell progeny in the rodent CNS
    Michelle S Bradbury
    Department of Radiology, Sloan Kettering Institute for Cancer Research, New York City, New York, USA
    J Neurochem 102:2029-39. 2007
    ..In conclusion, our data suggest that optical bioluminescence imaging can serve as an essential tool for the development of hESC-based grafting strategies in the CNS...
  36. ncbi Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay
    Muneyasu Urano
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Radiat Res 158:167-73. 2002
    ..For comparison, the tumor cell survivals were assayed after a dose of 20 Gy given in air at 5, 20 and 60 min after anesthesia. The result showed a decrease in cell survival only in tumors irradiated 20 min after an injection of Nembutal...
  37. ncbi Different strategies for reducing intestinal background radioactivity associated with imaging HSV1-tk expression using established radionucleoside probes
    Alessandro Ruggiero
    Department of Radiology, Cyclotron and Radiochemistry Core Facility, and Research Animal Resource Center, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mol Imaging 9:47-58. 2010
    ..The combination of Peptamen and Nulytely increased radiotracer elimination by increasing bowel motility without inducing dehydration...
  38. ncbi hNIS-IRES-eGFP dual reporter gene imaging
    Jiantu Che
    Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Mol Imaging 4:128-36. 2005
    ..These studies indicate the potential for a wider application of hNIS reporter imaging and translation into patient studies using radioisotopes that are currently available for human use for both SPECT and PET imaging...
  39. ncbi Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene
    Xu Chen
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Proc Natl Acad Sci U S A 106:7979-84. 2009
    ....
  40. ncbi Radiation exposure of computed tomography and direct intracoronary angiography: risk has its reward
    Pat Zanzonico
    Department of Medical Physics, Nuclear Medicine Section, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Am Coll Cardiol 47:1846-9. 2006
    ..When weighing the relative risks of alternative medical procedures, therefore, it is imperative that one consider the overall risk of the respective procedures...
  41. ncbi Image deconvolution in digital autoradiography: a preliminary study
    Mutian Zhang
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Med Phys 35:522-30. 2008
    ..Digital autoradiograms following deconvolution show improved sharpness and contrast relative to the unprocessed autoradiograms...
  42. ncbi Imaging hNET reporter gene expression with 124I-MIBG
    Maxim A Moroz
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Nucl Med 48:827-36. 2007
    ..We have extended this effort by constructing an internal ribosomal entry site (IRES)-linked hNET-green fluorescent protein (GFP) hybrid reporter gene for both nuclear and optical imaging...
  43. ncbi Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model
    Peter Brader
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mol Cancer Ther 6:2900-8. 2007
    ..However, the severity of tumor ischemia after permanent ligation of the hepatic artery limits our ability to image severe hypoxia in this animal model...
  44. ncbi Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET
    Christopher C Riedl
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10021, USA
    Radiology 248:561-70. 2008
    ....
  45. ncbi Multimodality registration without a dedicated multimodality scanner
    Bradley J Beattie
    Momorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mol Imaging 6:108-20. 2007
    ....
  46. ncbi Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI
    Stig Palm
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 44:1148-55. 2003
    ..MicroPET and MRI-based preclinical biodistribution and localization data were obtained and used to assess the therapeutic potential of (90)Y-trastuzumab monoclonal antibody (mAb) (anti-HER2/neu) against ovarian carcinoma...
  47. ncbi Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8
    Kim Kramer
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:5465-70. 2007
    ..We tested the toxicity, pharmacokinetics, and dosimetry of intraventricular iodine-131-labeled monoclonal antibody 3F8 (131I-3F8) targeting GD2-positive CNS/LM disease in a phase I clinical trial...
  48. ncbi Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer
    Sadek A Nehmeh
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:235-42. 2008
    ..The aim of this study was to evaluate the reproducibility of (18)F-FMISO intratumor distribution using two pretreatment PET scans...
  49. ncbi Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers
    Fuqiu He
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 68:8597-606. 2008
    ....
  50. ncbi Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas
    Michelle S Bradbury
    Department of Radiology, Sloan Kettering Institute for Cancer Research, New York, New York 10021, USA
    J Nucl Med 49:422-9. 2008
    ..Our goal was to develop a robust and reproducible method of kinetic analysis for the quantitative evaluation of tumor proliferation...
  51. ncbi PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer
    Pat B Zanzonico
    Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 45:1966-71. 2004
    ..0151 cGy/MBq]) is recommended for (18)F-FDHT...
  52. ncbi Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients
    Neeta Pandit-Taskar
    Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 47:1202-8. 2006
    ..Calculations using actual patient population characteristics resulted in lower organ dose estimates than more conservative reference models...
  53. ncbi Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET
    Jen-Chieh Tseng
    NYU Cancer Institute, Rita J. and Stanley H. Kaplan Comprehensive Cancer Center, NYU Gene Therapy Center, NYU School of Medicine, New York, New York 10016, USA
    J Nucl Med 47:1136-43. 2006
    ....
  54. ncbi Radioiodine fallout and breast-feeding
    Robert W Miller
    Clinical Genetics Branch, National Cancer Institute, Bethesda, MD 20892-7132, USA
    Radiat Res 164:339-40. 2005
    ..The rationale for suspension of breast-feeding after exposure to radioiodine in fallout is presented...